The DLC-1 -29A/T polymorphism is not associated with nasopharyngeal carcinoma risk in Chinese population

Genet Test. 2008 Sep;12(3):345-9. doi: 10.1089/gte.2007.0121.

Abstract

Deleted in liver cancer-1 (DLC-1), encoding a Rho GTPase-activating protein (GAP), is considered as a promising candidate tumor suppressor gene in nasopharyngeal carcinoma (NPC). The single-nucleotide polymorphism (SNP) -29A/T upstream of ATG start codon was found when gene mutation profile of DLC-1 in NPC was analyzed. To evaluate the correlation between SNP -29A/T in the promoter region of DLC-1 gene and risk of NPC, a total of 521 samples from a Chinese population, including 320 healthy individuals and 201 NPC patients, were collected for SNP analysis by PCR-single-strand conformation polymorphism and sequencing. The differences in allele and genotype frequencies between NPC patients and controls were tested using logistic regression statistical method. No significant differences were found in allele or genotype frequencies between NPC patients and controls or among different NPC clinical stages. Hence, our data indicate that the SNP -29A/T of DLC-1 gene is not associated with NPC susceptibility.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Asian People / genetics*
  • Carcinoma / genetics
  • Case-Control Studies
  • China
  • DNA Mutational Analysis
  • Female
  • GTPase-Activating Proteins
  • Gene Frequency
  • Humans
  • Male
  • Middle Aged
  • Nasopharyngeal Neoplasms / genetics*
  • Polymorphism, Genetic*
  • Polymorphism, Single Nucleotide
  • Polymorphism, Single-Stranded Conformational
  • Population Groups / genetics*
  • Risk Factors
  • Tumor Suppressor Proteins / genetics*
  • Young Adult

Substances

  • DLC1 protein, human
  • GTPase-Activating Proteins
  • Tumor Suppressor Proteins